Exclusive | Pfizer, Amgen among 22 strategic firms eyeing Hong Kong expansion: source
Global drug maker Pfizer and biotech firm Amgen, each valued at over HK$1 trillion (US$153 billion), are among 22 strategic enterprises…
Read More...
Read More...